NASDAQ:ICAD iCAD (ICAD) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free ICAD Stock Alerts $1.75 -0.02 (-1.13%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$1.75▼$1.8450-Day Range$1.41▼$1.9052-Week Range$1.14▼$3.97Volume212,483 shsAverage Volume119,185 shsMarket Capitalization$46.45 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get iCAD alerts: Email Address iCAD MarketRank™ Stock AnalysisAnalyst Rating0.00 Rating ScoreUpside/Downside185.7% Upside$5.00 Price TargetShort InterestHealthy1.06% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.32Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.79 out of 5 starsComputer And Technology Sector544th out of 590 stocksSurgical & Medical Instruments Industry91st out of 97 stocks 2.0 Analyst's Opinion Amount of Analyst CoverageiCAD has received no research coverage in the past 90 days.Read more about iCAD's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.06% of the float of iCAD has been sold short.Short Interest Ratio / Days to CoveriCAD has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iCAD has recently decreased by 39.15%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldiCAD does not currently pay a dividend.Dividend GrowthiCAD does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ICAD. Previous Next 1.8 News and Social Media Coverage News SentimentiCAD has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 5 news articles for iCAD this week, compared to 2 articles on an average week.Search InterestOnly 6 people have searched for ICAD on MarketBeat in the last 30 days. This is a decrease of -54% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added iCAD to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iCAD insiders have not sold or bought any company stock.Percentage Held by Insiders11.95% of the stock of iCAD is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.61% of the stock of iCAD is held by institutions.Read more about iCAD's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of iCAD is -14.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iCAD is -14.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiCAD has a P/B Ratio of 1.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about iCAD's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. About iCAD Stock (NASDAQ:ICAD)iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.Read More ICAD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ICAD Stock News HeadlinesMay 17 at 7:00 AM | investorplace.com3 Top Small-Cap Growth Opportunities in the AI EraMay 16 at 3:44 AM | finance.yahoo.comicad Inc (ICAD) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth and Operational ...May 15 at 8:00 AM | globenewswire.comiCAD Reports Financial Results for First Quarter Ended March 31, 2024May 14, 2024 | msn.comiCAD Q1 2024 Earnings PreviewMay 10, 2024 | afr.comMilitary tensions flare on the road to stability with ChinaMay 8, 2024 | globenewswire.comUPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024May 8, 2024 | americanbankingnews.comiCAD (ICAD) Scheduled to Post Earnings on WednesdayMay 2, 2024 | globenewswire.comiCAD to Report First Quarter 2024 Financial Results on May 15, 2024April 26, 2024 | newsweek.comWorld's Best Digital Health Companies 2024 - DiagnosticsApril 17, 2024 | msn.comiCAD (ICAD) Price Target Decreased by 15.94% to 4.93April 11, 2024 | globenewswire.comiCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual SymposiumApril 9, 2024 | globenewswire.comiCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk EvaluationApril 9, 2024 | finanznachrichten.deiCAD, Inc.: iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology MeetingApril 9, 2024 | msn.comIsraeli hospital uses new AI technology to revolutionize breast cancer diagnosesApril 8, 2024 | finance.yahoo.comiCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology MeetingApril 8, 2024 | globenewswire.comiCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology MeetingApril 5, 2024 | msn.comRAD-AID and iCAD Join Forces to Improve Breast Cancer Detection in Low-Resource SettingsApril 4, 2024 | msn.comiCAD Launches ProFound Cloud: Next-Gen AI Breast Health PlatformApril 3, 2024 | finance.yahoo.comiCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)April 2, 2024 | globenewswire.comiCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise ScaleMarch 19, 2024 | finance.yahoo.comiCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for RadiologistsMarch 16, 2024 | finance.yahoo.comICAD Apr 2024 2.500 callMarch 16, 2024 | finance.yahoo.comICAD Apr 2024 2.500 putMarch 14, 2024 | investorplace.comArtificial Intelligence, Real Profits: 3 Stocks to Outsmart the MarketMarch 13, 2024 | finanznachrichten.deiCAD, Inc.: iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial ResultsSee More Headlines Receive ICAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iCAD and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/12/2024Today5/18/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:ICAD CUSIPN/A CIK749660 Webwww.icadmed.com Phone(603) 882-5200Fax603-880-3843Employees67Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+185.7%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,850,000.00 Net Margins-15.20% Pretax Margin-26.09% Return on Equity-14.00% Return on Assets-10.32% Debt Debt-to-Equity RatioN/A Current Ratio4.71 Quick Ratio4.26 Sales & Book Value Annual Sales$17.32 million Price / Sales2.68 Cash FlowN/A Price / Cash FlowN/A Book Value$1.22 per share Price / Book1.43Miscellaneous Outstanding Shares26,540,000Free Float23,217,000Market Cap$46.45 million OptionableOptionable Beta1.36 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMs. Dana R. Brown (Age 59)President, CEO & Executive Chair Mr. Jonathan Go (Age 61)Chief Technology Officer Comp: $351.89kMr. Eric LonnqvistChief Financial OfficerMs. Michelle StrongChief Operations OfficerMs. Annette L. Heroux (Age 67)Vice President of Administration Comp: $174.9kBrian TestaChief People OfficerMr. Bill KeyesSenior VP of Global Sales OperationsMr. Vasu AvadhanulaChief Product OfficerMr. Peter GrahamSenior VP of North American SalesMore ExecutivesKey CompetitorsNortech SystemsNASDAQ:NSYSLiberty TripAdvisorNASDAQ:LTRPAAkoustis TechnologiesNASDAQ:AKTSData StorageNASDAQ:DTSTPodcastOneNASDAQ:PODCView All CompetitorsInstitutional OwnershipPerritt Capital Management Inc.Bought 9,717 shares on 5/15/2024Ownership: 0.531%First Eagle Investment Management LLCBought 22,000 shares on 5/9/2024Ownership: 2.661%AMH Equity LtdBought 128,800 shares on 5/7/2024Ownership: 0.488%Salem Investment Counselors Inc.Bought 73,904 shares on 4/11/2024Ownership: 0.278%View All Institutional Transactions ICAD Stock Analysis - Frequently Asked Questions What is iCAD's stock price target for 2024? 0 analysts have issued 12-month target prices for iCAD's stock. Their ICAD share price targets range from $5.00 to $5.00. On average, they anticipate the company's share price to reach $5.00 in the next year. This suggests a possible upside of 185.7% from the stock's current price. View analysts price targets for ICAD or view top-rated stocks among Wall Street analysts. How have ICAD shares performed in 2024? iCAD's stock was trading at $1.77 at the start of the year. Since then, ICAD stock has decreased by 1.1% and is now trading at $1.75. View the best growth stocks for 2024 here. When is iCAD's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our ICAD earnings forecast. How were iCAD's earnings last quarter? iCAD, Inc. (NASDAQ:ICAD) issued its quarterly earnings results on Tuesday, March, 12th. The technology company reported ($0.02) EPS for the quarter. The technology company had revenue of $4.74 million for the quarter. iCAD had a negative net margin of 15.20% and a negative trailing twelve-month return on equity of 14.00%. What is Michael Klein's approval rating as iCAD's CEO? 4 employees have rated iCAD Chief Executive Officer Michael Klein on Glassdoor.com. Michael Klein has an approval rating of 75% among the company's employees. What other stocks do shareholders of iCAD own? Based on aggregate information from My MarketBeat watchlists, some companies that other iCAD investors own include Inseego (INSG), Marvell Technology (MRVL), NVIDIA (NVDA), Aptiv (APTV), JD.com (JD), Advanced Micro Devices (AMD), Bilibili (BILI), Ambarella (AMBA), BioXcel Therapeutics (BTAI) and Telefonaktiebolaget LM Ericsson (publ) (ERIC). Who are iCAD's major shareholders? iCAD's stock is owned by a number of retail and institutional investors. Top institutional investors include First Eagle Investment Management LLC (2.66%), Perritt Capital Management Inc. (0.53%), AMH Equity Ltd (0.49%) and Salem Investment Counselors Inc. (0.28%). Insiders that own company stock include Andy Sassine, Charles Ross Carter, Dana R Brown, Jonathan Go, Michael S Klein, Stacey M Stevens, Susan Alyson Wood and Timothy Norris Irish. View institutional ownership trends. How do I buy shares of iCAD? Shares of ICAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ICAD) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iCAD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
